['melanoma']
['ipilimumab', 'nivolumab']

        For more information regarding BMS clinical trial participation, please visit
        www.BMSStudyConnect.com

        Inclusion Criteria:

          -  At least 15 years of age Except: where local regulations and/or institutional policies
             do not allow for subjects < 18 years of age (pediatric population) to participate. For
             those sites, the eligible subject population is ≥ 18 years of age

          -  Completely removed melanoma by surgery performed within 12 weeks of randomization

          -  Stage IIIb/C or Stage IV before complete resection

          -  No previous anti-cancer treatment

        Exclusion Criteria:

          -  Ocular or uveal melanoma

          -  History of carcinomatosis meningitis

          -  History of auto-immune disease

          -  Treatment directed against the resected melanoma that is administrated after the
             surgery

        Other protocol-defined inclusion/exclusion criteria apply
      